AVITA Medical Soars 10% on Revenue Growth and Optimistic Outlook

2 min read | February 14, 2025 11:50 AM AEDT | By Team Kalkine Media

AVITA Medical Soars 10% on Revenue Growth and Optimistic Outlook — Image source: shutterstock

Revenue Growth Amid Challenges

AVITA Medical posted a 30% rise in commercial revenue for the fourth quarter, reaching US$18.4 million. This contributed to full-year commercial revenue of US$64 million, marking a 29% increase compared to the previous fiscal year.

The company also reported a robust gross profit margin of 87.6% in Q4, bringing the full-year margin to 85.8%. However, these positive figures were overshadowed by a net loss of US$61.8 million, significantly higher than the US$35.4 million loss in FY 2023. Management attributed this increase to rising operating expenses and reduced other income.

Path to Profitability in FY 2025

Despite the net loss, AVITA Medical remains optimistic about its future financial performance. The company expects commercial revenue to grow substantially in FY 2025, projecting a range of US$100 million to US$106 million—an increase of approximately 55% to 65%.

More importantly, the company anticipates a turnaround in profitability. Management has indicated that AVITA is on track to generate free cash flow in the second half of FY 2025 and achieve GAAP profitability by the fourth quarter of the fiscal year.

Investor Confidence Boosted

Investors responded positively to the earnings report, sending AVITA Medical’s share price up by 10% on the ASX.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.